NovoMedix (United States)

Statistics

Publications

Citations

171

Authors

Location

San Diego, United States

NovoMedix (United States) is a company institution in San Diego, United States known for endothelial progenitor cell therapy, heart failure molecular mechanisms, and circulating hematopoietic stem cells.

Homepage ROR

Top concepts

FibrosisMedicineCardiologyPharmacologyHeart FailureGene ExpressionFibroblast ActivationStructural Heart DiseaseFibrotic Tissue RemodelingHeart Failure Pharmacology

Publications

A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure

Jessica Bradley, Pablo Spaletra, Zhen Li et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2018 · 20 citations · Full text

Medicine, Cardiology, Pharmacology +15

Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects

Nina Mikirova, James Jackson, Ron Hunninghake et al. · Journal of Translational Medicine · 2010 · 14 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17

1–2 of 14

Authors

CA
Cathy A. Swindlehurst
NovoMedix (United States), United States
19 publications · 181 citations
6
h-index

1–1 of 1